SCHEMBL4649873

SCHEMBL4649873

CSc1cc(C)c2nnc(C(N)=O)c(Nc3cncc(Cl)c3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.37
TDO2 P48775 1/20 0.36
SYK P43405 1/20 0.34
CSF1R P07333 2/20 0.32
BTK Q06187 3/20 0.32
TEC P42680 2/20 0.32
BMX P51813 2/20 0.32
LCK P06239 2/20 0.32
LYN P07948 1/20 0.32
HCK P08631 1/20 0.32
FGR P09769 1/20 0.32
SRC P12931 1/20 0.32
FRK P42685 1/20 0.32
BLK P51451 1/20 0.32
LIMK1 P53667 1/20 0.32
ACVR1 Q04771 1/20 0.32
TNK2 Q07912 1/20 0.32
ITK Q08881 1/20 0.32
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8238030 0.89 TDO2 (0.34) SLC2A1TDO2SYKCSF1RBTK
Hydrochloric Acid SCHEMBL4607073 0.88 TDO2 (0.34) SLC2A1TDO2SYKBTKTEC
SCHEMBL4607293 0.83 PDE4B (0.46) CSF1RLRRK2PDE4B
SCHEMBL4608167 0.82 LRRK2 (0.41) TDO2CSF1RLRRK2PDE4B
SCHEMBL4933226 0.82 SLC2A1 (0.35) SLC2A1CSF1RBTKTECBMX
SCHEMBL4607544 0.81 PDE4B (0.37) TDO2SYKCSF1RLIMK1JAK2
SCHEMBL4607333 0.78 BTK (0.34) CSF1RBTKJAK2JAK1LRRK2
SCHEMBL4607521 0.77 SLC2A1 (0.44) SLC2A1CSF1RBTKJAK2JAK1
SCHEMBL4607457 0.76 SLC2A1 (0.49) SLC2A1SYKBTKTECBMX
SCHEMBL4607911 0.75 PDE4B (0.51) SYKCSF1RPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280911-A1 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4) GLAXO GROUP LIMITED (GB) 2008-11-13 US disclosed
US-20080280911-A1 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4) GLAXO GROUP LIMITED (GB) 2008-11-13 US disclosed
US-20080280911-A1 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4) GLAXO GROUP LIMITED (GB) 2008-11-13 US disclosed
EP-1945616-A1 CINNOLINE COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASE TYPE IV (PDE4) GLAXO GROUP LIMITED (GB) 2008-07-23 EP disclosed
EP-1108733-B1 Propylene-ethylene block copolymer, resin composition, and blow-molded article PRIME POLYMER CO LTD (JP) 2008-05-07 EP disclosed
WO-2007037517-A9 CYCLIC OLEFIN RESIN FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY FUJIFILM CORP (JP) 2007-05-31 WO disclosed
WO-2007045861-A1 CINNOLINE COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASE TYPE IV (PDE4) GLAXO GROUP LIMITED (GB) 2007-04-26 WO disclosed
WO-2007045861-A1 CINNOLINE COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASE TYPE IV (PDE4) GLAXO GROUP LIMITED (GB) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280911-A1 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4) PDE4A, PDE4B, PDE3B SLC2A1 3751/4885TDO2 2966/4885SYK 4333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.